Supporting our speculation, RMS patient samples express several pluripotent cancer stem cell markers (CD24, CD133, Oct-4, Sox2, Nanog, and c-Myc) and are able to differentiate into neuronal cells, osteogenic cells, myocytes, and adipocytes85–87. Here, SOX2 is linked to cancer.